Cost Sharing and Branded Antidepressant Initiation Among Patients Treated With Generics
Higher cost sharing is associated with reduced branded antidepressant initiation among patients trying generic therapy. Dynamic benefit designs could enhance access to branded medications when appropriate.
Racial Differences in Switching, Augmentation, and Titration of Lipid-lowering Agents by Medicare/Medicaid Dual-eligible Patients
2 Clarke Drive Cranbury, NJ 08512